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PRAK  P38-regulated/activated protein kinase
SPR  Surface plasmon resonance
TH  Tyrosine hydroxylase
TH-pS19  TH phosphorylated on Ser19
bTH  Bovine TH
hTH  Human TH1
Introduction
Tyrosine hydroxylase (TH) is the first and rate-limiting 
enzyme in the biosynthesis of catecholamines (Nagatsu 
et al. 1964), important hormones and neuromodulators. 
The cellular activity of TH is regulated through several 
signaling pathways that target TH by Ser/Thr phosphoryla-
tion (Almas et al. 1992; Haycock et al. 1982; Haycock and 
Wakade 1992; Sutherland et al. 1993), and by protein–pro-
tein interactions with 14-3-3 proteins (Itagaki et al. 1999; 
Toska et al. 2002; Yamauchi et al. 1981). Whereas Ser40 
phosphorylation potently activates TH (Almas et al. 1992; 
Andersson et al. 1992; Sura et al. 2004), activation of TH 
by Ser19 phosphorylation (TH-pS19) requires 14-3-3 bind-
ing (Itagaki et al. 1999; Toska et al. 2002; Yamauchi et al. 
1981), although this activation of TH has been questioned 
by other studies (Haycock and Wakade 1992; Sutherland 
et al. 1993).
The 14-3-3 proteins are highly conserved throughout 
evolution and are encoded by multiple genes in all eukary-
otic species. Whereas yeast has two genes encoding 14-3-3 
proteins, plants and mammals have numerous genes (13 
Abstract Tyrosine hydroxylase (TH) is regulated by 
members of the 14-3-3 protein family. However, knowledge 
about the variation between 14-3-3 proteins in their regula-
tion of TH is still limited. We examined the binding, effects 
on activation and dephosphorylation kinetics of tyrosine 
hydroxylase (TH) by abundant midbrain 14-3-3 proteins 
(β, η, ζ, γ and ε) of different dimer composition. All 14-3-3 
homodimers and their respective 14-3-3ε-heterodimers 
bound with similar high affinity (Kd values of 1.4–3.8 nM) 
to serine19 phosphorylated human TH (TH-pS19). We 
similarly observed a consistent activation of bovine (3.3- 
to 4.4-fold) and human TH-pS19 (1.3–1.6 fold) across 
all the different 14-3-3 dimer species, with homodimeric 
14-3-3γ being the strongest activator. Both hetero- and 
homodimers of 14-3-3 strongly inhibited dephosphoryla-
tion of TH-pS19, and we speculate if this is an important 
homeostatic mechanism of 14-3-3 target-protein regulation 
in vivo. We conclude that TH is a robust interaction partner 
of different 14-3-3 dimer types with moderate variability 
between the 14-3-3 dimers on their regulation of TH.
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and 7 in Arabidopsis and mammals, respectively) cod-
ing for different 14-3-3 isoforms (Aitken 2006; Paul et al. 
2012). The mammalian 14-3-3s, except 14-3-3σ, are abun-
dantly expressed in the brain, with genes Ywha(b/g/e/h/s/q 
and z) corresponding to 14-3-3 proteins (β/γ/ε/η/σ/τ and 
ζ), respectively (Ichimura et al. 1988). The different mono-
mers can form homo- or heterodimers, and 14-3-3ε pref-
erentially and spontaneously forms heterodimers with the 
other isoforms (Chaudhri et al. 2003; Jones et al. 1995; 
Yang et al. 2006).
The notion that the various 14-3-3 proteins can combine 
into homo- and heterodimeric proteins has caused uncer-
tainty concerning the functional diversity across the differ-
ent 14-3-3 isoforms in terms of target binding specificity. 
This issue remains unresolved, particularly as binding to 
different 14-3-3 dimer combinations has been compared 
only for few target proteins. In particular, a quantitative 
comparison of binding affinity for different 14-3-3 homo- 
and heterodimer types is not available.
Several 14-3-3 proteins play important roles in the 
mature nervous system, as functional knockout (KO) mice 
show distinct morphological and behavioral abnormalities 
(Foote et al. 2015), whereas the 14-3-3ε isoform plays the 
most prominent role in neural development (Toyo-oka et al. 
2003). As 14-3-3ε preferentially forms heterodimers with 
other 14-3-3 isoforms (except 14-3-3σ) (Yang et al. 2006), 
this could suggest a particular functional importance of the 
heterodimeric 14-3-3s. KO studies of several 14-3-3 genes 
give abnormalities related to major neuropsychiatric disor-
ders, consistent with aberrant expression and association of 
several 14-3-3 isoforms with such disorders (Jacobsen et al. 
2015; Rivero et al. 2015). Thus, various effects on dopa-
mine-/noradrenergic neurotransmission have been reported. 
The KO model of 14-3-3ζ shows hyperactivity, possibly by 
altered regulation of the dopamine transporter (Ramshaw 
et al. 2013), and the heterozygous 14-3-3ε KO mice have 
an impaired development of tyrosine hydroxylase (TH) 
positive nerve terminals (Sekiguchi et al. 2011). Thus, the 
different 14-3-3 proteins may regulate monoamine trans-
mission and biosynthesis to variable degrees.
In vitro and cell studies suggest differences between the 
14-3-3 isoforms in their regulation of TH (Halskau et al. 
2009; Nakashima et al. 2007; Wang et al. 2009). We there-
fore wanted to study different isoforms of 14-3-3 in their 
binding and regulation of TH. In particular, we wanted to 
include the respective 14-3-3ε-heterodimers. Such 14-3-3 
heterodimers have been reported to display strong target 
specificity (Liang et al. 2008; Rajagopalan et al. 2010) and 
the 14-3-3ε KO mice show high lethality and dramatic neu-
rodevelopmental defects (Toyo-oka et al. 2003).
Using purified recombinant proteins as well as TH from 
native source, we performed a comparative study of the 
different hetero- and homodimers of mammalian 14-3-3 
isoforms that are reportedly expressed in dopaminergic 
midbrain neurons (β, γ, Ɛ, η, and ζ) (Wang et al. 2009). We 
measured the binding affinity of different 14-3-3 dimers 
to TH phosphorylated on Ser19, their effects on TH acti-




[32P-γ]ATP was from PerkinElmer (Georgia, USA). (6R)-
Tetrahydrobiopterin (BH4) and 6-methyl-tetrahydrobiop-
terin (6MPH4) was from Dr B. Schirck’s Laboratories (Jona, 
Switzerland). pGEX-2T plasmids for expression of 14-3-3γ, 
η, and ζ were gifts from Prof. Alastair Aitken (Edinburgh, 
UK), for 14-3-3β from Dr. C. James Hastie [MRC, Divi-
sion of Signal Transduction Therapy, University of Dundee 
(Scotland)] and pET11 for expression of his-tagged 14-3-3ε 
was from Prof. S.O. Døskeland (Department of Biomedi-
cine, University of Bergen). Active p38-regulated/activated 
protein kinase (PRAK) was from Merck Millipore (Darm-
stadt, Germany). Unless otherwise stated, reagents were 
from Sigma-Aldrich (St. Louis, MO, USA).
Protein expression and purification
Human TH1 was expressed as a (His)6-ZZ-hTH1 fusion 
protein in E. coli (BL21 Codon Plus (DE3), Stratagene, 
CA, US) using the pET-ZZ-1a vector (Kleppe et al. 2014). 
Expression was induced by 1 mM IPTG, for 4 h, 30 °C. 
Bacteria were lysed in 50 mM Tris buffer pH 7.5, 300 mM 
NaCl, 0.5 mg/ml Lysozyme, 1 U/ml Benzonase, Roche 
protease inhibitor cocktail, 10 mM benzamidine, 1 mM 
phenylmethyl-sulfonyl-fluoride (PMSF), on ice using 
French press, and purified using Ni–NTA metal affinity 
resin (Clontech, CA, US). The fusion tag was removed by 
proteolytic cleavage overnight on ice, using Tobacco etch 
virus protease [TeV, 1:50 (mg) TeV:TH] in 15 mM Hepes, 
pH 7.4, 150 mM NaCl, 1 mM DTT, 5 % glycerol. Sam-
ples were then centrifuged (13,000g, 10 min) and gel fil-
trated (Superdex 200 10/300 GL, GE Healthcare, UK) to 
remove the fusion partner. The preparation was checked by 
SDS-PAGE for homogeneity. Bovine TH was isolated from 
adrenal medulla (Haavik et al. 1988). His-tagged 14-3-3ε 
was expressed in E. coli using the pET11 expression vector 
and purification using Ni–NTA according to manufactur-
er’s protocol. GST-fused 14-3-3 isoforms (β, γ, η, ζ) were 
expressed in E. coli (BL21-CodonPlusDE3) and purified as 
described (Kleppe et al. 2014). The uncleaved GST-14-3-3s 
were used for Surface plasmon resonance measurements. 
For activity measurements and for dephosphorylation 
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experiments, we used the thrombin cleaved 14-3-3 proteins 
(20 U/mg fusion protein), with subsequent gel filtration 
(Superdex 75 10/300 GL, GE Healthcare, UK) in 15 mM 
Hepes, pH 7.4, 150 mM NaCl. The 14-3-3ε isoform spon-
taneously forms heterodimers when mixed with the other 
homodimers of 14-3-3 (Jones et al. 1995; Yang et al. 2006). 
See supplemental text for details on the preparations of dif-
ferent 14-3-3ε-heterodimers (Fig. S1).
TH phosphorylation, activity and dephosphorylation
The phosphorylation on Ser19 using PRAK was performed 
as described (Kleppe et al. 2014); giving phosphorylation 
stoichiometries between 0.2 and 0.8 mol phosphate/mol TH 
subunit (TH-pS19). TH activity was measured as described 
(Toska et al. 2002; Yamauchi et al. 1981). We performed 
dephosphorylation using lysate from PC12 cells (Leal 
et al. 2002). The PC12 cells were lysed in 50 mM Hepes, 
pH 7.4, 1 mM EDTA, 1 mM dithiothreitol (DTT), 0.1 % 
Triton-X100 and 2× protease inhibitor cocktail (Roche), 
before centrifugation at 13,000g (10 min) and removal of 
small molecules by three subsequent washes in spin fil-
ter microtubes (10 kDa cutoff). Dephosphorylation was 
performed using 25 mM HEPES (pH 7.2), 130 mM KCl, 
1 mM dithiothreitol, 1 mM EGTA, 1x protease inhibitor, 
1.25 mg/ml BSA, 5 µM (subunit) phosphorylated TH and 
8 µM 14-3-3 subunit, at 25 °C. TH was preincubated for 
5 min on ice in the presence or absence of 14-3-3 proteins 
prior to dephosphorylation (0.4 mg/ml PC12 lysate) and 
the rate of dephosphorylation was determined at conditions 
giving less than 20 % turnover. The assay was performed 
essentially as described by Cohen et al. (Cohen et al. 1988).
Surface plasmon resonance measurements
The interactions between hTH1 and 14-3-3 isoforms were 
studied using a Biacore 3000 instrument (GE Healthcare), 
essentially as described (Kleppe et al. 2014). GST-capture 
was used for all 14-3-3 dimers except for 14-3-3ε:ε, which 
was immobilized using direct amine coupling (10 mM Na-
acetate, pH 5.4). All binding studies were performed at 
25 °C in the standard HBS-P buffer, at flow of 30 μl/min. 
Sensograms were analyzed using the BIAevaluation v2.2 
program by non-linear curve fitting as described (Kleppe 
et al. 2014).
Structural analysis
The alignment of human YWHAB, YWHAE, YWHAG, 
YWHAH and YWHAZ, corresponding to 14-3-3β, ε, γ, 
η and ζ was performed in ClustalX (v 2.1) using default 
parameters. The structural analysis of 14-3-3ε (2BR9) was 
performed using Discovery Studio Visualizer (v 4.1).
Results and discussion
Homo‑ and heterodimers of 14‑3‑3 bind to TH‑pS19 
with similar affinities
Phosphorylation of TH at Ser 19 (TH-pS19) initiates 
binding to 14-3-3 proteins (Halskau et al. 2009; Itagaki 
et al. 1999; Kleppe et al. 2014). However, the binding 
kinetics of different 14-3-3 isoforms, and in particular 
that of different ε-heterodimers, have not been system-
atically compared. Using surface plasmon resonance 
(SPR), we measured the kinetics of Ser19-phosphorylated 
human TH1 (hTH-pS19) binding to 14-3-3 homo-/heter-
odimers (Fig. 1a,b). Overall, we found that the different 
14-3-3 dimers had very similar Kd-values (1.4–3.8 nM, 
Table 1). Comparison of the kinetics showed slightly 







































Fig. 1  Comparison of binding kinetics of different 14-3-3 dimers 
to TH-pS19. Binding of TH-pS19 to different immobilized 14-3-3 
dimers was measured using Biacore 3000. a SPR sensograms show-
ing binding between TH-pS19 (25 nM) and different 14-3-3 homodi-
mers (γ:γ black; η:η red; β:β blue; ζ:ζ gray). b SPR sensograms 
showing binding between TH-pS19 (25 nM) and different 14-3-3 
ε-heterodimers (ε:γ black; ε:η red; ε:β blue; ε:ζ gray). Sensograms 
were scaled to account for differences in GST-capture levels among 
the different 14-3-3 dimers and their Rmax value for TH-pS19 binding 
for a given GST-capture level
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larger differences in the rate constants between the 14-3-3 
dimers (maximally 2.4 or 3.1 fold difference between 
the different ka-values or the kd-values, respectively) 
(Table 1). Only the kd rate constants showed significant 
differences among the 14-3-3 dimers, with 14-3-3γ:γ 
and β:β having the fastest and slowest dissociation rates, 
respectively.
It could be speculated if such moderate differences 
in rate constants could lead to preferential accumula-
tion of TH:14-3-3 complexes containing certain 14-3-3 
dimers. However, this would depend on the signaling 
dynamics of the cell as well as the cellular availability 
of the different 14-3-3 dimer types. Cell studies have 
suggested a preferential interaction of TH with 14-3-3ζ 
over η (Wang et al. 2009). Here, we show that this is 
unlikely to be caused by differences in binding kinetics. 
Possibly, the 14-3-3 selectivity reported in cell studies 
are due to different cellular localization or availability 
of the two 14-3-3 proteins. Also, the 14-3-3η isoform 
has been reported to regulate TH stability in PC12 cells 
(Nakashima et al. 2007). Interestingly, 14-3-3η is also 
reported to interact with the E3-ubiquitin ligase Parkin, 
and regulated by α-synuclein (Sato et al. 2006). These 
findings suggest a more complex relationship between 
14-3-3 binding and its regulation. Thus, the observed 
complexes formed and the functional outcome could 
be a result of competitive interactions between differ-
ent 14-3-3 target proteins and, at least for TH, different 
14-3-3 dimer types.
Differential activation of TH by 14‑3‑3 isoforms
The 14-3-3 proteins are known as phosphorylation depend-
ent activators of TH and tryptophan hydroxylase (TPH) 
(Itagaki et al. 1999; Toska et al. 2002; Yamauchi et al. 
1981). However, conflicting results have been reported 
on their potency to activate TH (summarized in Table S1) 
(Haycock and Wakade 1992; Sutherland et al. 1993; Toska 
et al. 2002). We therefore compared the ability of differ-
ent 14-3-3 isoforms and heterodimers to modulate the 
activity of bovine and human TH (bTH and hTH), isolated 
from native and recombinant sources, respectively. Dif-
ferent assay conditions have been used in earlier reports 
Table 1  Binding kinetics for the complex between TH-pS19 and dif-
ferent 14-3-3 dimers
We measured the association and dissociation rate constants for bind-
ing of TH-pS19 to 14-3-3 isoforms using SPR (Methods). TH was 
phosphorylated on Ser19 using PRAK to a stoichiometry of 0.5 phos-
phates per subunit. Rate constants were fitted as described (Kleppe 
et al. 2014) and are given ± SEM, estimated by fitting each experi-
ment separately. The equilibrium dissociation constant (Kd) was 
calculated based on the rate constants (=kd/ka) and the dissociation 
half time (t0.5) on kd (t0.5 = ln(2)/kd). Single factor ANOVA of all ka 
and kd-values showed that only the kd constants differed significantly 
between the 14-3-3 dimer types (P = 8.5 10−5)
14-3-3 dimer ka (10
5 M−1s−1) kd (10
−3 s−1) Kd (nM) t0.5 (Min)
14-3-3ε:ε 2.6 ± 0.90 0.72 ± 0.10 2.8 16
14-3-3γ:γ 3.1 ± 1.5 0.94 ± 0.10 3.0 12
14-3-3ζ:ζ 1.3 ± 0.44 0.38 ± 0.07 2.9 30
14-3-3η:η 2.7 ± 0.80 0.44 ± 0.06 1.6 26
14-3-3β:β 2.2 ± 0.80 0.30 ± 0.02 1.4 38
14-3-3ε:γ 2.0 ± 1.0 0.50 ± 0.07 2.5 23
14-3-3ε:ζ 1.7 ± 0.86 0.65 ± 0.07 3.8 18
14-3-3ε:η 2.9 ± 1.1 0.48 ± 0.04 1.7 24

















































Fig. 2  Activation of TH by different 14-3-3 isoforms. TH phospho-
rylated by PRAK (TH-pS19) was assayed for activity in the presence 
or absence of different 14-3-3 isoform combinations (12.5–100 µg/
ml) to yield a 14-3-3 activation response curve. The maximal TH acti-
vation is reported here. Panel a shows the relative activation of bovine 
TH (PRAK phosphorylated) by different homo- and heterodimers 
of 14-3-3. All were significantly higher than the control (bTH-pS19 
without 14-3-3) (P < 1.0 10−5), with 14-3-3γ:γ as the most potent 
activator (P < 0.005). For all 14-3-3ε-heterodimers, except that of 
14-3-3η:η, the activation was slightly, but significantly lower com-
pared to that of their non-ε-homodimer (P < 0.05). Panel b shows 
the relative activation of hTH1 (PRAK phosphorylated) by different 
homo- and heterodimers of 14-3-3. All were significantly higher than 
the control (P < 0.0013), but less potent than 14-3-3γ:γ (P < 0.015, 
14-3-3ε:ε not significant). The 14-3-3ε-heterodimer of γ (P < 0.008) 
showed less potent activation of TH compared to its homodimeric 
form. All P values were calculated using the two-tailed t test and cor-
rected for multiple comparisons
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to measure 14-3-3 mediated TH activation. As it is known 
that the regulatory properties of TH are different in the 
presence of the natural cofactor 6R-tetrahydrobiopterin 
(BH4) compared to the synthetic analogue 6-methyltetrahy-
dropterin (6MPH4) used in early studies (Yamauchi et al. 
1981), we first performed a systematic comparison of TH 
activation using both 6MPH4 and BH4. The two cofactors 
gave similar activation of either bTH or hTH1 phosphoryl-
ated by PRAK, both for the mammalian 14-3-3 isoforms 
and for yeast 14-3-3 (BMH1). As we have previously 
shown, 14-3-3 binding has no effect on the Km of TH for 
BH4 (Toska et al. 2002). Also, we did not find a significant 
effect of 14-3-3 on the Km or substrate inhibition constant 
(Ksi) of TH for its substrate tyrosine.
Using BH4 as the cofactor we investigated, in more 
detail, possible differences between the various 14-3-3 
dimer types in their activation of bTH and hTH1 (Fig. 2). 
The activation of non-phosphorylated TH by different 
14-3-3 proteins was <14 % and that of BSA (50 µg/ml) on 
both TH and PRAK phosphorylated TH was <10 % (data 
not shown). However, we observed a strong activation (t 
test, P < 10−5) of bTH-pS19 ranging from 3.3- to 4.4-fold 
in the presence of different 14-3-3 dimers (Fig. 2a). Thus, 
the homodimer of 14-3-3γ gave the highest activation 
(P < 0.005; 14-3-3γ:γ different from other 14-3-3dimers), 
whereas the 14-3-3ζ:ε heterodimer gave the lowest activa-
tion. There was a slight, but significant difference between 
the homodimers in their activation of bTH-pS19, compared 
to their respective 14-3-3ε-heterodimer (P < 0.05). For the 
hTH-pS19 protein, we observed a similar, but much less 
pronounced activation by the 14-3-3 proteins (Fig. 2b). 
Thus, 29–55 % activation was observed (P < 1.3 × 10−3), 
with 14-3-3γ homodimer and 14-3-3ζ:ε as the most and 
least potent activators, respectively.
The bTH from native sources was clearly activated 
more strongly by 14-3-3 proteins than hTH produced in 
E. coli. We therefore tested if possible co-purified com-
ponents in the bTH preparation could potentiate the acti-
vation of hTH. However, we found no additional activa-
tion of the hTH by 14-3-3 proteins by mixing with either 
non-phosphorylated bTH or PRAK phosphorylated bTH. 
Thus, we suspect that the variable activation by 14-3-3s 
could be due to alterations in the state of the bTH protein 
itself, such as additional covalent or non-covalent pro-
tein modifications, oxidation or catecholamine binding. 
In line with this, we noted that the majority of studies 
reporting strong activation of TH by 14-3-3 proteins gen-
erally used TH prepared from native sources, including 
SF21 insect cells (Itagaki et al. 1999; Tanji et al. 1994; 
Yamauchi et al. 1981). Additionally, in intact systems, a 
differential effect of the 14-3-3 dimers on TH stability 
or turnover cannot be excluded (Nakashima et al. 2007; 
Nakashima et al. 2011).
The impact of 14‑3‑3 proteins on the dephosphorylation 
of TH
Major TH Ser/Thr phosphatases include Protein phos-
phatase 2A (PP2A) and 2C (PP2C) (Bevilaqua et al. 2003; 
Haavik et al. 1989; Leal et al. 2002). To mimic dephospho-
rylation of TH in cells, we used cell lysate from PC12 cells 
that contain intact and relevant protein complexes of these 
protein phosphatases. Such lysates have been used previ-
ously to assess TH dephosphorylation (Bevilaqua et al. 
2003) and were used here to investigate possible differ-
ences in the dephosphorylation of human TH-pS19 in the 
presence of different mammalian 14-3-3 homo- and het-
erodimers. All tested 14-3-3 homo/heterodimers strongly 
inhibited dephosphorylation of Ser19 (72–87 %) (Fig. 3). 
We have previously described the maximal binding of two 
14-3-3γ dimers for each TH-pS19 tetramer (Kleppe et al. 
2014). We also observed a mono-exponential dephospho-
rylation rate of TH-pS19 in the presence of 14-3-3γ sug-
gesting that all four sites are protected in the complex. 
Here, we observed a strong inhibitory effect of all the dif-
ferent 14-3-3 dimers on TH-pS19 suggesting similar modes 
of binding for the 14-3-3 proteins.
However, the inhibition appeared to be slightly different 
between the 14-3-3 dimers, 14-3-3ε:ε having the strong-
est inhibition and 14-3-3ζ:ζ having the weakest. Thus, the 
observed potency of dephosphorylation inhibition did not 
correspond with the rate of dissociation of the complex 
as measured by SPR. Theoretically, such effects can arise 
from different conformational states in the complexes and 
from multiple reaction steps in the association and dis-
sociation process. We have previously observed such rate 
differences between the kd-value measured using SPR and 




























Fig. 3  Dephosphorylation of TH in presence and absence of different 
14-3-3 s. The assay was performed at 25 °C for 5–10 min incubating 
10 µM 14-3-3 and 5 µM of phosphorylated TH with 0.4 mg/ml PC-12 
cell lysate as described in Methods. Dephosphorylation of TH-pS19 
(0.15 stoichiometry) was measured in presence and absence of differ-
ent 14-3-3 homo/hetero dimers. The error bars show the st.dev. from 
three different experiments (*P < 0.001, two-tailed t test)
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TH-pS19 was 50 % dephosphorylated <5 s. in absence of 
14-3-3) (Kleppe et al. 2014). However, injection of high 
levels of phosphatase during dissociation in the SPR meas-
urements gave a rate constant corresponding to the one 
measured in solution, suggesting multiple states for the 
TH:14-3-3 complexes. However, a detailed kinetic inves-
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missing in crystal structure
Fig. 4  Differences between surface-exposed amino acids of the 
14-3-3 isoforms studied. Panel a shows the alignment of human 14-3-
3ζ, β, γ, η and ε, where surface-exposed amino acid residues that dif-
fer between the isoforms are shaded in color coding; blue (14-3-3ζ 
and/or β differ from the rest), red (14-3-3ε different than the rest), 
green (14-3-3γ and/or η different), gray (differences between all 
groups) and orange (14-3-3ε and γ/η or ζ/β differ). The color cod-
ing is used correspondingly in the panels showing the surface struc-
ture of 14-3-3 (b–d). The amino acids that are part of α-helix I to IX 
are marked in the alignment. Panels b–d show the surface area of a 
subunit of human 14-3-3ε (2BR9). Gray surface is conserved between 
14-3-3ζ, β, γ, η and ε, whereas colored surface mark differences 
[according to color code in (a)]. Panel b shows the conserved bind-
ing groove of 14-3-3ε, with the dimerization interface exposed and 
the peptide binding site illustrated with an arrow. The colored amino 
acids that contribute to isoform variation of the conserved binding 
groove of 14-3-3 are marked by c.s (conserved surface) in the align-
ment. Panels c, d show the surface of 14-3-3ε obtained by rotating 
the view in panel (b) as illustrated. These surfaces correspond to the 
variable surface of the outer wall (c) and the outer floor (d) of the 
14-3-3 U-shaped structure. The amino acid numbering is according to 
residue numbers in 14-3-3ε
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Structural variation in the surface of the 14‑3‑3 isotypes
Few examples exist on comparable affinity analysis of dif-
ferent 14-3-3 dimers binding to the same target protein. 
The literature reports both selective and non-selective bind-
ing of 14-3-3 isoforms to target proteins, suggesting that 
the target proteins gain affinity by interacting with non-
conserved or conserved surface areas of 14-3-3 proteins, 
respectively, in addition to the phospho-Ser/Thr interaction 
site (Subramanian et al. 2001; Vincenz and Dixit 1996).
Analysis of the surface-exposed amino acids in the dif-
ferent 14-3-3 isoforms studied here (Fig. 4) suggests that 
selectivity of targets binding inside the binding groove of 
14-3-3 would mainly arise from interactions with the last 
amino acids of α-helix III (H-III) and the loop between 
H-III and H-IV (Fig. 4a, b). Interactions with surface areas 
on the outer side of the wall (H-V–H-IX) and the outer sur-
face of the floor (H-I–H-IV) of the binding groove would 
provide opportunities for selectivity over the whole surface 
area (Fig. 4c, d). Patches of red, green and blue, corre-
sponding to amino acid differences in 14-3-3ε, γ/η and ζ/β, 
respectively, suggest that selectivity between these groups, 
but rarely within, can be expected. The analysis also readily 
illustrates some of the unique features of 14-3-3ε.
Our data suggest that the TH-pS19:14-3-3 interaction 
is driven mainly by a surface interface that is conserved 
among the tested 14-3-3 isoforms. This would translate to 
the inner side of the binding groove, including the top of the 
wall (H-IX). Interactions with H-IX would provide close 
spatial vicinity to the acidic C-terminal of 14-3-3, which 
is a region without any structural resolution and of high 
amino acid diversity. Its acidity, viewed in context with the 
known activation of TH by heparin and the reported inhi-
bition of 14-3-3 binding by heparin, provides a plausible 
mechanism of TH activation by 14-3-3 proteins, which was 
somewhat different between the isoforms. The possible 
impact of 14-3-3 C-terminal in TH binding and activation, 
remains however, to be confirmed experimentally.
In the reported 14-3-3ζ:Serotonin N-acetyltransferase 
structure, there is evidence for extensive interactions 
within the binding groove of 14-3-3, where 34 of the 37 
amino acids that participate in the protein–protein inter-
actions are conserved between the 14-3-3 isoforms (Obsil 
et al. 2001). Although not directly compared, less 14-3-3 
isoform selectivity would therefore be expected for sero-
tonin N-acetyltransferase. The 14-3-3 target proteins 
RGS3 and phosducin show interactions outside the bind-
ing groove, in a less conserved area of 14-3-3 (Kacirova 
et al. 2015; Rezabkova et al. 2011). For neither RGS3 nor 
phosducin the binding affinities to the different 14-3-3 iso-
forms have been compared, although RGS3 is reported to 
interact with 14-3-3β and τ in addition to 14-3-3ζ (Benz-
ing et al. 2000; Niu et al. 2002; Rezabkova et al. 2011). Of 
the mapped interaction surface between 14-3-3 and RGS3, 
H-VI and H-VIII are areas that can give rise to isoform 
selectivity that would fit with its interaction with 14-3-3β, 
ζ and τ. This still needs to be experimentally tested, e.g. by 
mutagenesis, if it is in fact so, and whether such selectivity 
can be extended to a biological functional level. Still, the 
question about functional differences between 14-3-3 iso-
forms is one of the major unresolved issues in the biology 
of these proteins.
Conclusions
We have shown a robust interaction of TH-pS19 across 
multiple 14-3-3 dimer forms expected to be present 
in dopaminergic cells. This conserved interaction was 
reflected in a consistent activation of TH and inhibition of 
TH-dephosphorylation with moderate 14-3-3 isotype pref-
erences. Thus, we suggest the presence of different catego-
ries of 14-3-3 targets; those that convey isotype selectivity 
by large surface interactions on the outer surface of the 
phospho-Ser/Thr peptide binding channel, whereas others 
that interact non-selectively as the binding interface cov-
ers areas within the binding groove and the top of the wall 
(C-terminal H-IX). Access to such structural information 
will also be important for selective pharmacological target-
ing of 14-3-3 protein interactions.
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